Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

Events & Presentations

Upcoming Events

Past Events

Presentations

Date Title
Jan 13, 2020